Sources | Names Used |
---|---|
CTRPv2 | carboplatin:etoposide (40:17 mol/mol) |
PharmacoGx | carboplatin:etoposide (40:17 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NRF1 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-15 |
mRNA | H3F3A | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-14 |
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-14 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-14 |
mRNA | ANGEL2 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-14 |
mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-14 |
mRNA | TOP2A | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-14 |
mRNA | KHDRBS1 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-14 |
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-14 |
mRNA | HMGB2 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-14 |